HECG - Health Economics Consulting Group Logo
       
 
John M. Brooks, PhD
Biosketch | E-mail | Publications
 

Selected Publications:

Brooks JM, Irwin C, Hunsicker L, Flanagan M, Chrischilles E, Pendergast J, AEffect of Dialysis Center Profit-Status on Patient Survival: A Comparison of Risk-Adjustment and Instrumental Variable Approaches.@ Health Services Research (forthcoming).

Brooks JM, Klepser DG, Urmie JM, Farris KB, Doucette WR, “Effect of Local Competition on the Willingness of Community Pharmacies to Supply Medication Therapy Management Services,” Forthcoming in Journal of Health and Human Services Administration (forthcoming).

Chen-Hardee SS, Chrischilles EA, Voelker MD, Brooks JM, Scott SD, Link BK, Delgado DJ, “Population-based Assessment Of Hospitalizations For Neutropenia From Chemotherapy in Older Adults With Non-Hodgkin’s Lymphoma.” Cancer Causes and Control (forthcoming).

Ganther-Urmie JM, Farris KB, Doucette WR, Brooks JM, Fries DJ, Kuhle CL. “Medicare Beneficiaries’ Satisfaction and Experiences with a Prescription Drug Discount Card and Preferred Drug List:  The Iowa Priority Prescription Savings Program.” Journal of the American Pharmacists Association (forthcoming).

Chrischilles EA, Klepser DG, Brooks JM, Voelker MD, Chen-Hardee SS, Scott SD, Link BK, Delgado DJ. “Effect of Clinical Characteristics on Neutropenia-Related Inpatient Costs Among Newly Diagnosed Non-Hodgkin's Lymphoma Cases During First-Course Chemotherapy,” Pharmacotherapy, 25 (5), May 2005, pp 668-675.

Davila JA, Brooks JM, Pendergast JF, Chrischilles EA, “The Effect of Physician Characteristics and their Practice Environment on Surgical Referral Patterns for Early-Stage Breast Cancer,” American Journal of Medical Quality, 19(6) November-December 2004, pp 266-273.

Farris KB, Ganther-Urmie JM, Fang G, Doucette WR, Brooks JM, Klepser DG, Fries DJ, Kuhle CL, “Population-Based Medication Reviews:  A Descriptive Analysis of the Medication Issues Identified in a Medicare Not-for-Profit  Prescription Discount Program,” Annals of Pharmotherapy, 38(1) November 2004, pp 1823-1829.

Brooks JM, Chrischilles E, Scott S, Chen-Hardee S.  “Was Lumpectomy Underutilized for Early Stage Breast Cancer? Instrumental Variables Evidence for Stage II Patients from Iowa, ”  Health Services Research, December 2003. 38:6 Part 1; 1385-1402.

Klepser ME, Klepser DG, Ernst EJ, Brooks JM , Diekema DJ, Mozaffari E, Hendrickson J. “Healthcare Resource Utilization Associated with the Treatment of Penicillin-Susceptible and -Nonsusceptible Isolates of Streptococcus Pneumoniae.” Pharmacotherapy,  March 2003. 23(3); 349-359.

Motheral B, Brooks JM , Clark MA, Crown WH, Davey P, Hutchins D, Martin BC, Stang P.  “A Checklist for Retrospective Database Studies - Report of the ISPOR Task Force on Retrospective Databases.” Value in Health, March-April 2003. 6(2); 90-97.

Brooks JM , Doucette W, Sorofman BS.  “Third Party Bargaining and Contract Terms:  The Link Over Time.” Journal of the American Pharmaceutical Association, May/June 2002.  42(3); 420-27.

Lund BC , Perry PJ, Brooks JM , Arndt S.  “Clozapine Use in Patients with Schizophrenia and the Risk of Diabetes, Hyperlipidemia, and Hypertension:  A Claims-Based Approach.” Archives of General Psychiatry, December 2001. 58(12); 1172-1176

Doucette W, Brooks JM, Sorofman B, Hetrick, A.  “Bargaining Between Community Pharmacies and Third Party Payers: Influences on Bargaining Outcomes.” Journal of Managed Care Pharmacy, January/February 2001. 7(1); 43-49.

Brooks JM, Chrischelles E, Scott S, Ritho J, Chen-Hardee S.  “Information Gained from Linking SEER Cancer Registry Data to State-Level Hospital Discharge Abstracts?” Medical Care, November 2000.  38(11);1131-1140.

Brooks JM, McDonough R, Doucette W.  “Reimbursing Pharmaceutical Care:  Why Might Insurers Flinch?” Drug Benefit Trends, June 2000. 12(6);45-56.

Brooks JM, McClellan M, Wong H.  “The Marginal Benefits of Invasive Treatment for Acute Myocardial Infarction:  Does Insurance Coverage Matter?” Inquiry, Spring 2000.  37(1); 75-90.

Brooks JM, Doucette W, Sorofman B.  “Factors Affecting Bargaining Outcomes Between Pharmacists and Insurers,” Health Services Research, April 1999.   34(1, Part II); 439-451.

Brooks JM, Sorofman S, Doucette W.  “Varying Health Care Provider Objectives and Cost-Shifting:  The Case of Retail Pharmacy in the U.S. ” Health Economics, March, 1999.  8(2);137-150.

Doucette W, Brooks JM, Sorofman B.  "Market Factors and the Availability of Community Pharmacy Services."  Clinical Therapeutics, July 1999.  21(7);1267-1279.

Brooks JM, Dor A, Wong H.  "The Impact of Physician Payments on Hospital-Insurer Bargaining in the US," in Governments and Health Systems, D. Chinitz, M. Cohen (eds.), New York:  J. Wiley and Sons, 1998.

Brooks JM, Dor A, Wong H.  "The Hospital-Insurer Bargaining Process:  An Empirical Investigation of Appendectomy Pricing," Journal of Health Economics, August 1997.  16(4); 417-434.

Brooks JM, Kirking D. "Effect of Production Environment on Labor Demand in Veterans Affairs Medical Center Pharmacies", American Journal of Health-Systems Pharmacy , April 15, 1995,  52;812-822.

 
Health Economics Consulting Group